The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
Clint Schick, Chief Executive, Strata Health UK, describes a software system that has made the manual process...digital – freeing up staff time & improving patient care.
Rapidly scaling health-tech player in the emerging Pathology Computer Aided Diagnostics sector Deciphex uses digital pathology and AI to accelerate pathology diagnosis by improving productivity and patient outcome.
Specialists in acute care Draeger Medical UK Ltd prioritise patient wellbeing and efficiency in holistic approach to a well-designed healthcare workplace
Brian Murphy, CSO of UK digital health firm Cumulus Neuroscience, explores how AI tools could transform drug development in the difficult area of cognitive disorders.
Ms Bel Wong, Dr Kenny Chui and Prof Timothy Kwok from the Jockey Club Centre for Positive Ageing, walk us through a programme that supports people with younger onset dementia (YOD).
Andrew Metcalfe, Director of Intelligent Infection Control Services Limited, LumiBio, discusses the benefits of utilising existing technologies to mitigate the ongoing staff shortages in the NHS.
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
An algorithm can predict the severity of COVID patients' illnesses depending on how many of them will be highly likely or unlikely to need intensive care or ventilation.
Researchers at University of East Anglia have discovered that a prostate cancer urine test could improve the identification of men at ‘immediate risk’ of aggressive cancer, offering improved treatment methods.
A home test kit enabling patients with Breast cancer to test their blood nears its final development stages, with support from the NHS and inventors Entia and Pfizer.
Doris-Ann Williams MBE, CEO, BIVDA, calls for increased community testing as a way to clear the NHS backlog and deal with the increasing number of people who are living with undiagnosed diseases in the UK.
